Company Number: 15875640

Analysis Date: 2025-07-29 18:50 UTC

Financial Health Assessment for EH2024 LIMITED

---

1. Financial Health Score: D

Explanation:
EH2024 LIMITED is in the very early stage of its lifecycle, having been incorporated in August 2024 with financials covering only a short period (Aug to Oct 2024). The company shows significant liabilities relative to its assets, resulting in a very low net asset value (£2). This fragile balance sheet, combined with negative net current assets and minimal cash, signals early symptoms of financial distress, warranting a cautious outlook.

---

2. Key Vital Signs

Metric	Value	Interpretation
Cash in Hand	£2	Extremely low liquidity; hardly any cash reserves for daily operations.
Current Liabilities	£147,349	High short-term obligations; urgent need for working capital management.
Net Current Assets	-£147,347	Negative working capital; company may struggle to meet short-term debts.
Total Assets less Current Liabilities	£598,153	Appears healthy due to significant fixed asset investments.
Creditors due after 1 year	£598,151	Very high long-term liabilities, almost matching total net assets.
Net Assets / Shareholder Funds	£2	Indicates extremely thin equity base, signaling potential solvency concerns.
Share Capital	£200	Minimal equity injection; capital base extremely limited.
Industry Classification	Dormant Company (SIC 99999)	No trading activity reported; may be newly formed or awaiting operations.

---

3. Diagnosis: Financial Condition Assessment

EH2024 LIMITED is essentially in its infancy, with minimal equity capital and a heavy debt load dominated by a large long-term creditor balance (£598,151). The company’s balance sheet shows it has invested heavily (£745,500) in subsidiaries (notably 100% ownership of Eurospars Ltd), which may be the primary operational entity. However, the company itself holds very little cash and faces a working capital deficit, indicated by negative net current assets (-£147,347). This is analogous to a patient with a significant underlying condition (large liabilities) but no immediate cash reserves ("healthy blood flow") to sustain day-to-day functions, risking liquidity crisis.

The classification as a "Dormant Company" implies no trading activity yet or minimal transactions, which aligns with the very short reporting period and lack of profit & loss disclosures. The directors have not submitted a profit and loss account, which is permissible under small company exemptions but limits insight into operational performance.

Overall, the company's financial health is fragile, with a high risk of liquidity distress if operational cashflows do not improve rapidly. The substantial investment in subsidiaries suggests strategic intent, but the company itself currently lacks robust financial resilience.

---

4. Recommendations: Actions to Improve Financial Wellness

• Strengthen Liquidity Position:
  Increase cash reserves either through equity injection or short-term financing to ensure the company can meet immediate liabilities and avoid a cash crunch.

• Review Debt Structure:
  The large long-term liabilities (£598k) need to be carefully managed. Consider refinancing options to improve terms or negotiate repayment schedules that align with cash flow forecasts.

• Operational Commencement and Revenue Generation:
  Move from dormant status to active trading to generate revenue and enhance cash flows. Early revenue generation is critical to improve working capital and reduce reliance on debt.

• Regular Financial Monitoring:
  Implement robust cash flow forecasting and management practices to diagnose liquidity "symptoms" early and take corrective action.

• Explore Equity Funding:
  Seek new equity investors or additional capital from existing shareholders to build a stronger equity base and reduce leverage risks.

• Intercompany Transactions Transparency:
  Monitor and document intercompany loans, especially the £100,000 owed to the subsidiary, to ensure clear financial reporting and avoid confusion in consolidated financial health.

---